Figure 3From: The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma Comparisons of the area under the receiver operating curve for survival status between scoring systems at 6 month (a), 12 month (b), 18 month (c), and 24 month (d). Back to article page